首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression.
【24h】

Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression.

机译:维生素E抑制环孢菌素A,H2O2促进人B细胞的爱泼斯坦-巴尔病毒(EBV)转化,通过EBV致癌基因LMP1表达进行分析。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We have previously shown that oxidative stress induced by H2O2 or cyclosporin A (CsA) can promote Epstein-Barr virus (EBV) transformation of human B cells as analyzed by colony formation, cell number, and by 3H-thymidine incorporation. In this report, we used EBV oncogene LMP1 as a marker to analyze H2O2 or CsA promotion of EBV transformation of human B cells and to test whether antioxidant vitamin E could inhibit H2O2 or CsA promoted LMP1 expression in the EBV-infected cells. MATERIALS AND METHODS: Human splenocytes were prepared by centrifugation and plating technique to provide a greater than 80% pure preparation of B cells and were used for EBV infection. The EBV infected cells were treated with H2O2 (0.1 mM, 10 min), or with CsA (500 ng/ml) with or with out vitamin E (40 microM). The cells were cultured for up to 4 weeks. Samples were taken every week and were stained with phycoerythrin-conjugated mouse anti-LMP1 monoclonal antibody to assay LMP1 positive population by flow cytometry. RESULTS: In EBV-infected cells, the LMP1-positive cell population reached 14% after 4 weeks of culture. CsA or H2O2 treatment promoted LMP1 positive population to 43% and 41% after 4 weeks of culture. Vitamin E (40 microM) completely inhibited LMP1 expression in EBV-infected cells and in CsA- or H2O2-treated cells. CONCLUSION: In agreement with our previous observation, CsA or H2O2 can promote EBV transformation of human B cells. This oxidative stress induced promotion of EBV transformation can be blocked by antioxidant Vitamin E. This finding may have future therapeutic implications for post-transplant lymphoproliferative disorder.
机译:背景:我们先前已经证明,H2O2或环孢菌素A(CsA)诱导的氧化应激可通过克隆集落形成,细胞数目和3H-胸苷掺入分析促进人B细胞的爱泼斯坦-巴尔病毒(EBV)转化。在本报告中,我们使用EBV致癌基因LMP1作为标记来分析H2O2或CsA促进人B细胞的EBV转化,并测试抗氧化剂维生素E是否可以抑制H2O2或CsA促进EBV感染的细胞中LMP1的表达。材料与方法:通过离心和平板技术制备人脾细胞,以提供纯度大于80%的B细胞制剂,并用于EBV感染。用H2O2(0.1 mM,10分钟)或CsA(500 ng / ml)加或不加维生素E(40 microM)处理EBV感染的细胞。将细胞培养长达4周。每周采集样品,并用藻红蛋白缀合的小鼠抗LMP1单克隆抗体染色,以通过流式细胞术测定LMP1阳性群体。结果:在EBV感染的细胞中,培养4周后LMP1阳性细胞数量达到14%。培养4周后,CsA或H2O2处理将LMP1阳性人群提高到43%和41%。维生素E(40 microM)完全抑制EBV感染的细胞以及经CsA或H2O2处理的细胞中LMP1的表达。结论:与我们之前的观察结果一致,CsA或H2O2可以促进人B细胞的EBV转化。抗氧化剂维生素E可以阻止这种氧化应激诱导的EBV转化促进。这一发现可能对移植后的淋巴增生性疾病具有未来的治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号